News

Month Year

Month Year

Aruvant Sciences Presents Data from Ongoing Clinical Study of Lentiviral Gene Therapy RVT-1801 for Sickle Cell Disease at 60th Annual Meeting of the American Society of Hematology

Dec 3, 2018

Two patients have been administered RVT-1801 in conjunction with reduced intensity conditioning regimens
Roivant Launches Aruvant Sciences and Roivant Foundation in Partnership with Cincinnati Children’s Hospital Medical Center

Nov 26, 2018

Show per page